Home » Development of a trial of preventative treatments for those at risk of rheumatoid arthritis » Development of a trial of preventative treatments for those at risk of rheumatoid arthritis

Development of a trial of preventative treatments for those at risk of rheumatoid arthritis

Healthcare professional discussing information with patient

Research theme

Inflammatory arthritis

Patient and Public Involvement and Engagement (PPIE) case study

Aim

We aimed to develop a trial design for evaluating preventative interventions for people at risk of rheumatoid arthritis through the consultation of a Public Advisory Group.

Methods

We used online meetings, emails and a feedback form to interact with the 25 public contributors involved.

Involvement included

We involved public contributors in:

  • developing grant application
  • developing an online feedback form
  • giving feedback on trial design issues
  • designing a study of patient treatment preferences
  • developing lay summary, preparation of PPI plans and role description

Best practice

Public contributors noted:

  • an inclusive environment where they felt listened to and respected by the researchers
  • clear emails and adequate notice were received
  • researchers showed a genuine interest and motivation to improve the quality of PPIE in research
  • received prompt feedback on impact of contributions from public contributors

Impact of PPIE

  • Public contributors advised on the selection of outcome measures and recruitment of patient groups.
  • They informed consent procedures for the trial which have been incorporated into the trial protocol.
  • They suggested undertaking an additional treatment preference study which is being delivered alongside the trial.
  • Manuscript was submitted to a scientific journal with 12 PPI co-authors.

Latest case studies